JP2023502940A5 - - Google Patents
Info
- Publication number
- JP2023502940A5 JP2023502940A5 JP2022528026A JP2022528026A JP2023502940A5 JP 2023502940 A5 JP2023502940 A5 JP 2023502940A5 JP 2022528026 A JP2022528026 A JP 2022528026A JP 2022528026 A JP2022528026 A JP 2022528026A JP 2023502940 A5 JP2023502940 A5 JP 2023502940A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962935479P | 2019-11-14 | 2019-11-14 | |
| US62/935,479 | 2019-11-14 | ||
| PCT/US2020/060389 WO2021097192A1 (en) | 2019-11-14 | 2020-11-13 | Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502940A JP2023502940A (ja) | 2023-01-26 |
| JPWO2021097192A5 JPWO2021097192A5 (https=) | 2023-11-20 |
| JP2023502940A5 true JP2023502940A5 (https=) | 2023-11-20 |
Family
ID=75912341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022528026A Pending JP2023502940A (ja) | 2019-11-14 | 2020-11-13 | 溶解素－抗微生物ペプチド（ａｍｐ）ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220411473A1 (https=) |
| EP (1) | EP4058468A4 (https=) |
| JP (1) | JP2023502940A (https=) |
| WO (1) | WO2021097192A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210330738A1 (en) * | 2018-03-29 | 2021-10-28 | Contrafect Corporation | Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria |
| WO2023081913A1 (en) * | 2021-11-08 | 2023-05-11 | Emory University | Wild boar cathelicidin peptide variants and vectors encoding the same for uses in managing coronavirus infections |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2699689A4 (en) * | 2011-04-21 | 2014-12-17 | Univ Utrecht Holding Bv | STREPTOCOCCUS BACTERIOPHAGEN LYSINE FOR THE TREATMENT OF GRAM-POSITIVE BACTERIA IN PETS AND UTILITIES |
| WO2012159774A1 (en) * | 2011-05-26 | 2012-11-29 | Dsm Ip Assets B.V. | Novel listeria bacteriophage p825n and uses thereof |
| US8790639B2 (en) * | 2012-03-28 | 2014-07-29 | The United States Of America, As Represented By The Secretary Of Agriculture | Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin |
| WO2019118632A1 (en) * | 2017-12-12 | 2019-06-20 | Contrafect Corporation | Identification of lysins and derivatives thereof with bacterial activity against pseudomonas aeruginosa |
| WO2019191633A2 (en) * | 2018-03-29 | 2019-10-03 | Contrafect Corporation | Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof |
| US20210330738A1 (en) * | 2018-03-29 | 2021-10-28 | Contrafect Corporation | Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria |
| US10988520B2 (en) * | 2018-03-29 | 2021-04-27 | Contrafect Corporation | Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof |
-
2020
- 2020-11-13 EP EP20887858.7A patent/EP4058468A4/en active Pending
- 2020-11-13 WO PCT/US2020/060389 patent/WO2021097192A1/en not_active Ceased
- 2020-11-13 US US17/776,375 patent/US20220411473A1/en not_active Abandoned
- 2020-11-13 JP JP2022528026A patent/JP2023502940A/ja active Pending